DDrare: Database of Drug Development for Rare Diseases

Chloroquine diphosphate 250mg (DrugBank: Chloroquine)

3 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	0
49	Systemic lupus erythematosus	0
95	Autoimmune hepatitis	1

46. Malignant rheumatoid arthritis [ 4,183 clinical trials, 2,538 drugs, (DrugBank: 401 drugs), 183 drug target genes, 219 drug target pathways]

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 4,183 trial found

49. Systemic lupus erythematosus [ 827 clinical trials, 638 drugs, (DrugBank: 168 drugs), 108 drug target genes, 191 drug target pathways]

Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 827 trial found

95. Autoimmune hepatitis [ 44 clinical trials, 57 drugs, (DrugBank: 26 drugs), 18 drug target genes, 108 drug target pathways]

Searched query = "Autoimmune hepatitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 44 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01980745 (ClinicalTrials.gov)	February 2002	24/9/2013	CHLOROQUINE FOR MAINTENANCE REMISSION OF AUTOIMMUNE HEPATITIS	DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL WITH CHLOROQUINE VERSUS PLACEBO FOR MAINTENANCE OF REMISSION OF AUTOIMMUNE HEPATITIS	Hepatitis, Autoimmune	Drug: Chloroquine diphosphate 250mg;Drug: Placebo	University of Sao Paulo General Hospital	NULL	Completed	18 Years	70 Years	Both	61	Phase 4	Brazil